Latest news
Latigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTWegovy Boosts Chong Kun Dang's Sales, Lifts Drug Development Hopes - Seoul Economic DailySeoul Economic Daily · Wed, 05 Aug 2026 00:03:26 GMTAmgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment - WSJWSJ · Tue, 04 Aug 2026 20:14:00 GMTDash Bio Raises $30M in Series A Funding to Develop Automated Bioanalysis Platform for Drug Discovery - AI InsiderAI Insider · Tue, 04 Aug 2026 11:52:11 GMTDash Bio Raises $30 Million Series A to Modernize Bioanalysis for Drug Development - citybizcitybiz · Mon, 03 Aug 2026 14:40:45 GMTGSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs - ReutersReuters · Wed, 29 Jul 2026 07:00:00 GMT